231 related articles for article (PubMed ID: 24455802)
1. Unexplained cardiac failure leading to the identification of a Belgian family affected by hereditary amyloidosis.
De Pasqual A; Biessaux Y; Blettard N; Crémers S; Caers J
Acta Clin Belg; 2013; 68(4):303-5. PubMed ID: 24455802
[TBL] [Abstract][Full Text] [Related]
2. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
[TBL] [Abstract][Full Text] [Related]
3. Cardiac involvement after liver transplantation in patients with Val30Met transthyretin amyloidosis from Majorca focus.
Ripoll-Vera T; Alvarez J; Buades J; Cisneros E; Gomez Y; Melia C; Ferrer A; Losada I; Gonzalez J; Uson M; Figuerola A
Amyloid; 2019; 26(sup1):18-19. PubMed ID: 31343328
[No Abstract] [Full Text] [Related]
4. Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.
Hirakawa K; Takashio S; Marume K; Yamamoto M; Hanatani S; Yamamoto E; Sakamoto K; Izumiya Y; Kaikita K; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Yamashita Y; Ando Y; Tsujita K
ESC Heart Fail; 2019 Feb; 6(1):122-130. PubMed ID: 30284755
[TBL] [Abstract][Full Text] [Related]
5. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
Coelho T; Maurer MS; Suhr OB
Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
[TBL] [Abstract][Full Text] [Related]
6. From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis.
Petkow-Dimitrow P; Rajtar-Salwa R; Holcman K; Kostkiewicz M; Rubiś P
Pol Arch Intern Med; 2020 Feb; 130(2):153-154. PubMed ID: 31933485
[No Abstract] [Full Text] [Related]
7. Cardiac and peripheral vasomotor autonomic functions in hereditary transthyretin amyloidosis with non-Val30Met mutation.
Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
Amyloid; 2019; 26(sup1):13-14. PubMed ID: 31343285
[No Abstract] [Full Text] [Related]
8. Trajectory of left ventricular geometry and diastolic dysfunction in hereditary transthyretin cardiac amyloidosis.
Akatsuka T; Fujimoto N; Ishiyama M; Nakamori S; Imanaka-Yoshida K; Dohi K
ESC Heart Fail; 2021 Aug; 8(4):3422-3426. PubMed ID: 34145794
[TBL] [Abstract][Full Text] [Related]
9. Cardiac involvement in a large cohort of patients with Val30Met transthyretin amyloidosis from Majorca focus.
Ripoll-Vera T; Alvarez J; Buades J; Cisneros E; Gomez Y; Melia C; Ferrer A; Losada I; Gonzalez J; Uson M; Figuerola A
Amyloid; 2019; 26(sup1):15-16. PubMed ID: 31343338
[No Abstract] [Full Text] [Related]
10. Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: a case report.
Kon T; Misumi Y; Nishijima H; Honda M; Suzuki C; Baba M; Inomata Y; Obayashi K; Ando Y; Tomiyama M
Amyloid; 2015; 22(3):203-4. PubMed ID: 26123280
[No Abstract] [Full Text] [Related]
11. Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.
Matsushima M; Yabe I; Tsuda M; Sakakibara M; Shimamura T; Sasaki H
Intern Med; 2017 Dec; 56(23):3231-3235. PubMed ID: 28943540
[TBL] [Abstract][Full Text] [Related]
12. Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis.
Gopal DM; Ruberg FL; Siddiqi OK
Curr Heart Fail Rep; 2019 Oct; 16(5):180-188. PubMed ID: 31520266
[TBL] [Abstract][Full Text] [Related]
13. Amyloid heart disease mimicking hypertrophic cardiomyopathy.
Mörner S; Hellman U; Suhr OB; Kazzam E; Waldenström A
J Intern Med; 2005 Sep; 258(3):225-30. PubMed ID: 16115295
[TBL] [Abstract][Full Text] [Related]
14. Transthyretin amyloidosis in patients with undifferentiated heart failure.
Chang IC; Scott CG; Dispenzieri A; AbouEzzeddine O; Lin G; Grogan M
Amyloid; 2019; 26(sup1):33-34. PubMed ID: 31343280
[No Abstract] [Full Text] [Related]
15. Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis.
Damy T; Judge DP; Kristen AV; Berthet K; Li H; Aarts J
J Cardiovasc Transl Res; 2015 Mar; 8(2):117-27. PubMed ID: 25743445
[TBL] [Abstract][Full Text] [Related]
16. A case of transthyretin-related cerebral amyloid angiopathy. The other side of hereditary transthyretin amyloidosis.
Lemarchant B; Lebouvier T; Delbeuck X; Gibier JB; Tard C
Acta Neurol Belg; 2022 Apr; 122(2):571-573. PubMed ID: 35040071
[TBL] [Abstract][Full Text] [Related]
17. Cardiac amyloidosis with gastrointestinal involvement: a case report.
Tantau A; Avram I; Cozma A; Sampelean D
Med Ultrason; 2015 Mar; 17(1):123-5. PubMed ID: 25745667
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure.
Arvanitis M; Chan GG; Jacobson DR; Berk JL; Connors LH; Ruberg FL
Amyloid; 2017 Dec; 24(4):253-255. PubMed ID: 29052438
[No Abstract] [Full Text] [Related]
19. Cardiovascular autonomic functions in late-onset hereditary transthyretin amyloidosis with Val30Met mutation.
Nakamura T; Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
Amyloid; 2019; 26(sup1):6. PubMed ID: 31343341
[No Abstract] [Full Text] [Related]
20. Clinical manifestations in hereditary amyloidosis with the variant Glu54Gln transthyretin.
Jercan A; Badelita S; Draghici M; Stoica E; Iacob S; Coriu D
Amyloid; 2019; 26(sup1):31-32. PubMed ID: 31343281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
